News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

Asthma Inhalers to Incorporate Adherence-friendly Features

Asthma Inhalers Evolving to Incorporate Adherence-friendly Features

Greystone Research Associates Examines New-Generation Devices and their Impact on Patient Behavior

Amherst, NH, February 11, 2013 – The inhaled respiratory market represents one of the largest categories of drug spending, with continuing growth due to the increasing diagnosis of conditions such as asthma and COPD. As the incidence of these conditions increases, there exists a growing and significant opportunity to improve and expand current treatment of diseases of the upper respiratory tract.

Asthma continues to be a health segment that presents challenges to the caregiver community. Patient adherence with prescribing instructions and treatment protocols remains sub-optimal across all patient categories, but particularly for the young and the elderly. This has led to significant interest on the part of device and combination product providers directed toward the development easier-to-use inhalers. The new generation of oral asthma inhalers incorporates features and design elements that address this initiative, enabling devices that are more user-friendly and safe, and that as a result support the goal of improved patient adherence.

The current trend in asthma inhaler evolution has seen an increase in the incorporation of ergonomic features by device designers aimed at increasing patient receptiveness. Recent inhaler designs have approached the goals of improved usability and patient adherence from a number of distinct directions, including dose preparation technology, dose packaging, novel formulation technology, dosing confirmation, and symptoms monitoring.

A comprehensive analysis of advanced feature devices for asthma drug therapeutics is included in a new and comprehensive report. The report, Asthma Inhalers – The New Generation: Devices, Markets, Players and Prospects , includes assessments of devices, device features and asthma therapeutic markets, analysis of market factors, and profiles of market participants.

More information is available at www.greystoneassociates.org

About Greystone

Greystone Research Associates is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. We assist medical and healthcare market participants in achieving their business objectives through the creation of detailed development strategies, product commercialization programs, and comprehensive market and technology research and analysis. Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets.

ENDS

© Scoop Media

 
 
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 
Wellington Rugby Zeroes: Sevens To Move To Hamilton

Wellington Mayor Justin Lester: “The Sevens has been a big part of recent Wellington history but it was time for the event to move on… Wellingtonians have been voting with their feet in the last few years and we’ve seen the result in dwindling crowd numbers and lower ticket sales.” More>>

ALSO:

Matafeo & Dravid: The Billy T And Fred Award Winners For 2017

At the final show of the 2017 NZ International Comedy Festival powered by Flick Electric Co. the Festival came to a close after 115 shows in Auckland and 68 shows in Wellington. More>>

Scoop Review Of Books: What’s Fair? Tax and Fairness

This is an excellent and timely book, since apart from general statements about increasing or mostly reducing tax, there has been very little comment or debate as to whether we should pay tax at all and how much tax should each of us pay. More>>

Ockham Awards: Globally Lauded Novelist Wins NZ’s Biggest Fiction Prize

Internationally renowned Ngāruawāhia resident Catherine Chidgey has won New Zealand’s richest writing award, the $50,000 Acorn Foundation Fiction Prize, for her novel The Wish Child. More>>

ALSO:

 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION
 
 
  • Wellington
  • Christchurch
  • Auckland